RNAi-Mediated Knockdown of IKK1 in Transgenic Mice Using a Transgenic Construct Containing the Human H1 Promoter
Loading...
Identifiers
Publication date
Advisors
Tutors
Editors
Journal Title
Journal ISSN
Volume Title
Publisher
Hindawi
Abstract
Inhibition of gene expression through siRNAs is a tool increasingly used for the study of gene function in model systems, including
transgenic mice. To achieve perdurable effects, the stable expression of siRNAs by an integrated transgenic construct is necessary.
For transgenic siRNA expression, promoters transcribed by either RNApol II or III (such as U6 or H1 promoters) can be used.
Relatively large amounts of small RNAs synthesis are achieved when using RNApol III promoters, which can be advantageous in
knockdown experiments. To study the feasibility of H1 promoter-driven RNAi-expressing constructs for protein knockdown in
transgenic mice, we chose IKK1 as the target gene. Our results indicate that constructs containing the H1 promoter are sensitive
to the presence of prokaryotic sequences and to transgene position effects, similar to RNApol II promoters-driven constructs. We
observed variable expression levels of transgenic siRNA among different tissues and animals and a reduction of up to 80% in IKK1
expression. Furthermore, IKK1 knockdown led to hair follicle alterations. In summary, we show that constructs directed by the H1
promoter can be used for knockdown of genes of interest in different organs and for the generation of animal models complementary
to knockout and overexpression models.
Description
Keywords
Bibliographic citation
Moreno-Maldonado, R., Murillas, R., Navarro, M., Page, A. et al. (2014). RNAi-Mediated Knockdown of IKK1 in Transgenic Mice Using a Transgenic Construct Containing the Human H1 Promoter. "The Scientific World Journal", 193803
Relation
Has part
Has version
Is based on
Is part of
Is referenced by
Is version of
Requires
Publisher version
https://doi.org/10.1155/2014/193803Sponsors
This research was supported by Grants from the Spanish government (Ministerio de Economía y Competitividad: SAF2010-22156 to Angel Ramirez and PI10/01480 to M. Llanos Casanova and Instituto de Salud Carlos III: RD12/0036/0009) and from the Comunidad Autonoma de Madrid (52011/BMD2470)
Rights
Copyright © 2014 Rodolfo Moreno-Maldonado et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited







